Loading clinical trials...
Loading clinical trials...
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by Positron Emission Tomography in Patients With Known or Suspected Coronary Artery Disease (Ammonia MAP)
Conditions
Interventions
Myocardial Perfusion Imaging Study
AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]
Locations
5
United States
Doral Imaging Institute, LLC dba CIRA
Miami, Florida, United States
Doral Imaging Institute, LLC DBA CIRA Miami Beach
Miami Beach, Florida, United States
Adler Institute for Advanced Imaging
Jenkintown, Pennsylvania, United States
UPMC
Pittsburgh, Pennsylvania, United States
Molecular Imaging Technologies
El Paso, Texas, United States
Start Date
September 14, 2020
Primary Completion Date
August 16, 2024
Completion Date
August 16, 2024
Last Updated
September 5, 2024
NCT06863155
NCT06779630
NCT05461729
NCT03854071
NCT05681702
NCT07451522
Lead Sponsor
Ionetix Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions